Positive results from Influenza Human Challenge Study conducted by hVIVO
Positive results from Influenza Human Challenge Study conducted by hVIVO
mutex to present positive Phase I clinical study results for AGS-v PLUS mosquito vaccine candidate AGS-v PLUS mosquito vaccine candidate shows favourable safety, tolerability, and immunogenicity results
Open Orphan plc (AIM: ORPH), a rapidly growing specialist contract research organisation (CRO) and world leader in vaccine and antiviral testing using human challenge clinical trials , announces that hVIVO
£1.5m Contract renewal for Venn Life Sciences with a major global pharmaceutical client
Open Orphan plc (AIM: ORPH), a rapidly growing specialist contract research organisation (CRO) and world leader in vaccine and antiviral testing using human challenge clinical trials , announces the appointment
As nightfall creeps up ever earlier on us and we begin to wake up in the dark, searching for the comfort of our warmest and cosiest clothing before leaving the
Open Orphan Executive Chairman Cathal Friel joins Yahoo Finance Live to discuss how his company is testing vaccines through intentional infection.
Open Orphan plc (AIM: ORPH), a rapidly growing specialist clinical research organisation (CRO) and world leader in vaccine and antiviral testing using human challenge clinical trials , announces that hVIVO
Open Orphan plc (AIM: ORPH), a rapidly growing specialist contract research organisation (CRO) and world leader in vaccine and antiviral testing using human challenge clinical trials , announces that its
RSV Human Challenge Study conducted by hVIVO yields positive results
Open Orphan plc (AIM: ORPH), a rapidly growing specialist contract research organisation (CRO) and world leader in vaccine and antiviral testing using human challenge clinical trials , announces that hVIVO
Development of Controlled Human Malaria Infection Human Challenge Study hVIVO to assist in the advancement of antimalarial drug and vaccine candidates from November 2021